Author details

Full Name

Anna Weiss

Affiliation

ORCID

Career Start Year

2003

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37291442	ASO Visual Abstract: Value of Ambulatory Modified Radical Mastectomy.		2023
35941343	Nodal Positivity in Early-Stage Triple-Negative Breast Cancer: Implications for Preoperative Immunotherapy.	Ann Surg Oncol	2023
37675333	Breast reconstruction with latissimus dorsi flap: a comprehensive review and case series.		2023
37743213	Latissimus dorsi flap with immediate fat transfer (LIFT) for autologous breast reconstruction: Single institution experience.		2023
37563435	Predictors for Prolonged TE-to-Implant Exchange During Implant-Based Breast Reconstruction: A Single Institution Experience.		2023
37625107	Financial Toxicity Monitoring in a Randomized Controlled Trial of Patient-Reported Outcomes During Cancer Treatment (Alliance AFT-39).	J Clin Oncol	2023
37156648	De-escalation of axillary surgery in patients outside Z0011 criteria.		2023
37342011	Individualizing Breast Cancer Surveillance According to Tumor Subtype.		2023
36587173	Local Regional Recurrence Rates Are Low Following Neoadjuvant Endocrine Therapy: What Are the Remaining Barriers to its Widespread Adoption?		2023
37210568	Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer: Evidence and Controversies.	Oncologist	2023
37462051	Unraveling the "ta-da" moments of implementation in quality improvement.		2023
37266947	Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial.	JAMA	2023
37453148	Autologous breast reconstruction with latissimus dorsi flap in obese patients: Time-to-event analysis.		2023
37194964	Impact of Neoadjuvant Paclitaxel/Trastuzumab/Pertuzumab on Breast Tumor Downsizing for Patients with HER2+ Breast Cancer: Single-Arm Prospective Clinical Trial.	J Am Coll Surg	2023
37129846	ASO Author Reflections: It's Time to Get the Patient Perspective on Same-Day Mastectomy.		2023
37436607	Intraoperative Pathology Assessment May Lead to Overtreatment of the Axilla in Clinically Node-Negative Breast Cancer Patients Undergoing Upfront Mastectomy.		2023
37166742	Value of Ambulatory Modified Radical Mastectomy.		2023
37495843	Endocrine Therapy for Surgeons: Practical Pearls for Managing Menopausal, Bone Loss and Sexual Adverse Effects.		2023
34897706	Breast cancer-The catalyst of contemporary trials design.	J Surg Oncol	2022
35900704	Rates of pathologic nodal disease among cN0 and cN1 patients undergoing routine axillary ultrasound and neoadjuvant chemotherapy.	Breast Cancer Research and Treatment	2022
35763229	Sentinel Lymph Node Biopsy Alone is Adequate for Chemotherapy Decisions in Postmenopausal Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer with One to Three Positive Sentinel Lymph Nodes.	Annals of Surgical Oncology	2022
36096572	What Is the Role of Neoadjuvant Endocrine Therapy for Breast Cancer?		2022
35752703	The prevalence and predictors of adjuvant chemotherapy use among patients treated with neoadjuvant endocrine therapy.	Breast Cancer Research and Treatment	2022
35810227	ASO Visual Abstract: Sentinel Lymph Node Biopsy Alone is Adequate for Chemotherapy Decisions in Postmenopausal Early-Stage, Hormone-Receptor-Positive, HER2-Negative Breast Cancer with 1-3 Positive Sentinel Lymph Nodes.	Annals of Surgical Oncology	2022
35688521	Regional Nodal Management After Preoperative Systemic Therapy.	Seminars in Radiation Oncology	2022
35737367	Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer.	JAMA Oncol	2022
35797438	Preventive strategies for breast cancer-related lymphedema: Working toward optimal patient selection.	Cancer	2022
35609361	National Cancer Database trends in surgical resection of the breast primary for stage IV breast cancer.	Surg Oncol	2022
35668306	Surgical Management and Contralateral Breast Cancer Risk in Women with History of Radiation Therapy for Hodgkin Lymphoma: Results from a Population-Based Cohort.	Annals of Surgical Oncology	2022
35661856	Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial.	JAMA	2022
35338407	ASO Author Reflections: Is It Necessary to Routinely Clip and Localize the Biopsy-Proven Malignant Lymph Node?	Annals of Surgical Oncology	2022
34919263	Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: Results from a population-based cohort.	Cancer	2022
35041097	How Often Does Retrieval of a Clipped Lymph Node Change Adjuvant Therapy Recommendations? A Prospective, Consecutive, Patient Cohort Study.	Annals of Surgical Oncology	2022
34636255	Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1Â + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer.	Future Oncol	2021
33851312	ASO Author Reflections: Accurately Predicting Nodal pCR Holds the Key to Axillary Surgery De-escalation Strategies.	Annals of Surgical Oncology	2021
33720478	Extrapolation of ACOSOG Z0011 trial results-A survey of breast cancer providers.	Breast J	2021
32869154	Axillary Management After Neoadjuvant Endocrine Therapy for Hormone Receptor-Positive Breast Cancer.	Annals of Surgical Oncology	2021
33423122	Uptake of Breast Cancer Clinical Trials at Minority Serving Cancer Centers.	Ann Surg Oncol	2021
34499101	Neoadjuvant Endocrine Therapy in Clinical Practice: A Review.	JAMA Oncology	2021
31399819	Use of Mammographic Measurements to Predict Complications After Nipple-Sparing Mastectomy in BRCA Mutation Carriers.	Ann Surg Oncol	2020
32821803	Prognostic significance of residual nodal disease after neoadjuvant endocrine therapy for hormone receptor-positive breast cancer.	npj Breast Cancer	2020
32591951	The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cancer.	Annals of Surgical Oncology	2020
33112661	Clinical Utility and User Perceptions of a Digital System for Electronic Patient-Reported Symptom Monitoring During Routine Cancer Care: Findings From the PRO-TECT Trial.	JCO Clin Cancer Inform	2020
33058105	Strategies to Optimize Axillary Surgery in Patients With Breast Cancer Receiving Neoadjuvant Endocrine Therapy.	Oncology	2020
32771654	Association Between Time to Operation and Pathologic Stage in Ductal Carcinoma in Situ and Early-Stage Hormone Receptor-Positive Breast Cancer.	Journal of the American College of Surgeons	2020
31342389	Surgical Management of the Axilla in Clinically Node-Positive Patients Receiving Neoadjuvant Chemotherapy: A National Cancer Database Analysis.	Annals of Surgical Oncology	2019
31625045	Challenges in Clinical Trial Implementation: Results from a Survey of the National Accreditation Program of Breast Centers (NAPBC).	Ann Surg Oncol	2019
31562601	Patterns of Axillary Management in Stages 2 and 3 Hormone Receptor-Positive Breast Cancer by Initial Treatment Approach.	Annals of Surgical Oncology	2019
31228134	Prognostic Significance of Residual Axillary Nodal Micrometastases and Isolated Tumor Cells After Neoadjuvant Chemotherapy for Breast Cancer.	Annals of Surgical Oncology	2019
31132433	Excellent Locoregional Control in Inflammatory Breast Cancer With a Personalized Radiation Therapy Approach.	Pract Radiat Oncol	2019